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1. introduction 
The interaction of steroid hormone receptors with 
the genome of the target cells has attracted much at- 
tention. This interaction is considered responsible for 
the regulation of specific gene expression by steroid 
hormones. In [ 1,2] pyridoxal5’.phosphate was ob- 
served to inhibit the binding of steroid hormone recep- 
tors to immobilized DNA or nucleotides [ 1,2]. Pyri- 
doxal phosphate may also operate in vivo modulating 
the interaction of the glucocorticoid receptor with 
the hepatic cell nuclei [3]. The 4’.aldehyde group of 
pyridoxal5’.phosphate was shown to be required for 
the interaction with the glucocorticoid receptor [4]. 
Reduction with NaBH4 leads to irreversible loss of 
DNA binding activity, suggesting the formation of a 
Schiff base intermediate [5]. 
Very little is known, however, on the protein spec- 
ificity of this pyridoxal phosphate effect. In fact 
pyridoxal5’.phosphate could have a general inhibitory 
effect on DNA binding proteins simply due to its abil- 
ity to react with amino groups in the active site, thus 
interferring with electrostatic interactions. To explore 
this question we have investigated the influence of 
pyridoxal phosphate on DNA binding activity of puri- 
fied hepatic glucocorticoid receptor [6], of the 
Escherichia coli lac-repressor, and of other DNA-bind- 
ing proteins present in liver cytosol. We have found 
that similar concentrations of pyridoxal 5’.phosphate 
inhibit specific as well as non-specific binding to DNA. 
2. Materials and methods 
[3H]Triamcinolone acetonide (25 Ci/mmol), d[3H]- 
CTP (30 Ci/mmol) and d [Q-~‘P] CTP (400 Ci/mmol) 
were purchased from the Radiochemical Center, 
ElsevierlNorth-Holland Biomedical Press 
Amersham. E. coli DNA polymerase grade I and pyri- 
doxal 5’.phosphate, were obtained from Boehringer, 
Mannheim. lac-Operator DNA, the purified Zac-repres- 
sor and isopropylthiogalactoside (IPTG) were kindly 
gifted by K. Beyreuther, Koln. Nick-translation of 
operator DNA and A-DNA was done as in [7] using 
either d [ 3H] CTP or d [32P] CTP as label. The specific 
activity of the DNA probes is indicated in the legend 
to the corresponding experiments. 
The activated glucocorticoid receptor of rat liver 
was purified as previously reported [6]. 
2.1. DNA-binding assay 
The reactions were done in 25 ~1 assays, containing 
binding buffer (10 mM Tris-HCI (PH 7.4), 10 mM 
KCl, 10 mM MgC12, 0.5 mM dithioerythritol, 0.1 mg/ 
ml bovine serum albumin), DNA-binding proteins and 
the radioactive DNA probes. When the effect of pyri- 
doxal5’-phosphate was tested, the proteins were in- 
cubated for 5 min at room temperature with various 
concentrations of the drug prior to addition of the 
labelled DNA. Incubation was then continued for 20 
min at room temperature and the reaction mixture 
was filtered through nitrocellulose filter (Gelman GN-6, 
0.45 pm, 6 mm diam.). Prior to the binding assay the 
filters were boiled 10 min in binding buffer minus 
bovine serum albumin, and washed several times in 
complete binding buffer. After binding the filters 
were washed twice with 50 /.d binding buffer, dried 
and counted in a toluene-based scintillator. 
3. Results 
h preliminary experiments the amount of gluco- 
corticoid receptor required to retain 20-30% of the 
labelled DNA on the filter disc was determined. When 
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1 ng DNA was used 2-5 ng receptor were needed to 
obtain this percentage of retention. The influence of 
pretreatment of the receptor with pyridoxal phosphate 
on its binding to X-DNA in solution is shown in fig.la. 
These findings confirm results obtained with DNA- 
cellulose and crude receptors preparations [4], and 
show that mM levels of pyridoxal phosphate are suf- 
ficient to inhibit the DNA binding activity of the 
purified receptor. 
To answer the question whether other DNA-bind- 
ing proteins present in liver cytosol are also affected 
by pyridoxal phosphate, we first deprived the cytosol 
of activated receptor by passing it through a phospho- 
cellulose column [6], then tested the influence of 
pyridoxal phosphate on the DNA-binding activity of 
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the flow-through fraction (fig.Ia). There is a consider- 
able DNA binding activity in this fraction, in fact 
much more than in the phosphocellulose-bound frac- 
tion containing the activated receptor. As with the 
purified receptor, mM levels of pyridoxal phosphate 
inhibit the DNA binding activity of this crude hepatic 
preparation. To make sure that the DNA binding activ- 
ity in the crude protein fraction is not due to the resid- 
ual non-activated receptor, we compared the thermal 
stability of both functions: steroid binding and DNA- 
binding (fig.2). It is clear that whereas the receptor is 
rather thermolabile and looses its radioactive steroid 
between 40-45”C, the DNA binding activity of the 
crude fraction is not reduced at this temperature. In 
addition, the DNA-binding activity of the purified 
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Fig.1. Effect of pretreatment with pyridoxal 5’-phosphate on the DNA-binding activity of hepatic proteins and the k-repressor. 
(a) Purified activated glucocorticoid receptor from rat liver (2 ng) (o), or the flowthrough fraction of a phosphocellulose column 
(4 pg) (o) were incubated with several concentrations of pyridoxal5’-phosphate, and their DNA-binding activity was determined 
using a filter binding assay and 1 ng h-DNA labelled with 3zP to spec. act. 2 X 1 O7 cpm/pg. (b) Purified k-repressor from E. coli 
(50 ng) was incubated with several concentrations of pyridoxal 5’-phosphate and its DNA-binding activity was tested with operator 
DNA (0) (40 ng, labelled with 3H to spec. act. lo5 cpm/pg) and with A-DNA (o) (50 ng, labelled with 3H to spec. act. 1.7 X 10’ 
cpm/pg). The abscissa shows the final concentration of pyridoxal5’-phosphate in the 25 ~1 assays, and the ordinate the DNA 
bound to the filter as percentage of the control assay in the absence of pyridoxal phosphate. The blanks observed with DNA alone, 
were <5% of these control values and have been deduced from all experimental values. These blanks were not influenced by pyri- 
doxal phosphate. The results represent the average and standard error of 2 expt carried out in duplicate. 
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Fig.2. Influence of temperature on steroid binding and DNA 
binding activity of the glucocorticoid receptor and other 
hepatic proteins. The flowthrough fraction of a phospho- 
cellulose column (o), and the purified glucocorticoid receptor 
(o-o) were heated at the indicated temperature for 10 min, 
chilled, and their DNA-binding activity tested with “P-label- 
led h-DNA (spec. act. 3.5 X 10’ cpm/rg). The values are 
expressed as % of control samples that were kept in ice. Ali- 
quots of the flowthrough reaction were also used to investi- 
gate the steroid-binding activity remaining after incubation 
at the indicated temperature, using the charcoal technique 
[6]. The values are given as % of the unheated controls (0). 
receptor was thermolabile (fig.2). These findings sug- 
gest, therefore, that the DNA-binding activity of 
hepatic cytosol proteins other than the receptor is 
also similarly inhibited by pyridoxal 5’-phosphate. 
To test the generality of this finding, and to clear 
the question whether sequence specific binding is 
also affected by pyridoxal phosphate we studied the 
influence of this drug on the binding of the Zuc-repres- 
sor of E. coli to operator and non-operator DNA (fig. 
1 b). The specificity of the binding reaction was con- 
firmed by the inhibitory influence of the inducer IPTC 
(not shown). As in the case of the hepatic proteins 
there is an inhibition of DNA binding at mM levels 
of pyridoxal phosphate. Moreover, there is no marked 
difference between the sensitivy to the drug of sequence 
specific binding to operator DNA and non-specific 
binding to &DNA. 
4. Discussion 
In [8] the activated glucocorticoid receptor of rat 
liver bound to immobilized DNA of several sources 
without evident sequence specificity. We now confirm 
those observations obtained with crude cytosol prep- 
arations, that binding of steroid receptors to DNA- 
cellulose can be inhibited by pyridoxal S’-phosphate 
[l-5]. In addition, they show that the inhibition of 
DNA-binding activity by pretreatment with pyridoxal 
phosphate is a rather general phenomenon common 
to several DNA-binding proteins including an hetero- 
geneous population of hepatic proteins and the luc- 
repressor of fZ. coli. It is probable that this inhibition 
results from the interaction of the 4-aldehyde func- 
tion of pyridoxal phosphate with lysine residues in 
the active site, although this specific question was 
not addressed in these experiments. Moreover, not 
only the unspecific DNA binding as studied with the 
hepatic proteins but also the sequence specific bind- 
ing of the lac-repressor to the Zac-operator is inhibited 
by preincubation with pyridoxal phosphate. The elec- 
trostatic interaction of the amino groups of proteins 
and the phosphates of DNA, thus, seems to contrib- 
ute markedly to the specific binding of regulatory 
proteins to DNA. It is of course possible that the ef- 
fect of pyridoxal phosphate is indirect, and mediated 
through allosteric interactions with sites other than 
the DNA-binding site; further studies on the nature of 
the inhibition are required to clarify this point. 
The use of pyridoxal 5’-phosphate to elute the 
glucocorticoid receptor from DNA-cellulose columns, 
as has been recommended [9, lo], may be less specific 
than originally thought. Our findings do not exclude 
the possibility that pyridoxal phosphate acts as a 
modulator of the nuclear binding of the glucocorticoid 
receptor [3], but show that this function, if actually 
operative, is more general and not restricted to steroid 
hormone receptors. 
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